Lawrenceville-based Helomics Corp. has reached a master research and development agreement with the University of Pittsburgh to collaborate in the development and commercialization of new and existing intellectual property and technologies.

The five-year agreement came on the heels of Helomics’ partnership with South Side-based Scope International USA Inc., a contract research organization, to co-market products and services while developing new business opportunities with potential partners in the pharmaceutical, clinical diagnostics and other industries.

Helomics, a cancer diagnostics company that marketed its first product in 2005, is a privately held company that develops personalized medicine products.

It was founded in 1995 and purchased by a group of investors including Franklin Park native and Pitt graduate Gerald Vardzel in December.

Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699